If you are a woman 35-42, you may qualify for an IVF cycle at no cost with an investigational drug. To learn more, call Patty Pursue at 401-453-7500.
Women & Infants Hospital is participating in a national, randomized study to investigate the efficacy of a new fertility drug that would require one weekly injection rather than daily injections to simulate ovaries to make follicles. Women between the ages of 35 and 42 may qualify for an in vitro fertilization (IVF) cycle at no cost with the investigational drug. For information, call Patty Pursue at the Center for Reproduction and Infertility at (401) 453-7500. Press Release
Researchers at Brown University and Women & Infants have built an artificial human ovary that can grow oocytes into mature human eggs in the laboratory. That development could help preserve fertility for women facing chemotherapy or other treatments. Learn More and watch the story that appeared on Ch 10.
Unfortunately, some infertility patients cannot seek treatment because of insurance restrictions, income or other barriers. With this in mind, the Center for Reproduction and Infertility has become a proud member of Lance Armstrong's Livestrong’s Sharing Hope Program with a goal of increasing access to fertility preservation services for cancer patients. Learn More
The Program for Fertility Preservation at Women & Infants now offers options for fertility preservation in children, working in coordination with the Division of Oncology at Hasbro Children’s Hospital. Learn More
Women & Infants Ranks 26th in Gynecology in U.S. News Media Group's 2010-11 Best Hospitals
Women & Infants to Open New Center for Reproduction and Infertility
Women & Infants Signs Contract with Lance Armstrong Foundation to Provide Discounted Fertility Services
Women & Infants Physician Elected Vice President of Professional Board
Women & Infants Provides Fertility Preservation for Childhood Cancer Survivors
Women & Infants' Physician Accepted Into Scholars and Leaders Program